This Saturday the scientific discussion in Spain focuses on the reasons why the country was left out of a strong alliance of European powers for the massive manufacture of vaccines against Covid19. Possible cause, lack of an infrastructure that can effectively respond to this challenge.
France, Germany, Italy and the Netherlands formed what they called the ‘Alliance for Inclusive Vaccines’ and are joining forces in negotiations with potential developers and manufacturers of a coronavirus vaccine.
“Together, the 4 countries are exploring promising vaccine initiatives and are in talks with various pharmaceutical companies. They intend to manufacture the vaccines in Europe if possible,” says the official statement from the signatory governments.
Many countries want to have a coronavirus vaccine as soon as possible and are investing heavily in various research initiatives.
France, Germany, Italy and the Netherlands firmly believe that a common strategy and joint investments are crucial to success in this area.
“Therefore, they agreed to form the ‘Inclusive Vaccines Alliance’. According to the alliance, one of the most urgent issues is to accelerate the development process and guarantee global access to an effective vaccine,” the declaration document emphasizes.
The alliance is working hard to explore promising vaccine development initiatives to secure enough coronavirus vaccines for EU countries and beyond. Working together puts countries in a better position to achieve rapid and optimal results in their discussions with key stakeholders in the pharmaceutical industry when it comes to promising vaccine initiatives.
The alliance also wants pharmaceutical companies to agree that any vaccine developed must be accessible, available and affordable anywhere in the EU.
The 4 countries want to involve the European Commission in the negotiations and give other EU member states the opportunity to participate in initiatives resulting from the alliance.
This will allow everyone in Europe, and especially those who are most vulnerable, to benefit from a vaccine. The alliance is also working to make a portion of the vaccines available to low-income countries, including in Africa.